O'Malley S S, Jaffe A J, Chang G, Schottenfeld R S, Meyer R E, Rounsaville B
Department of Psychiatry, Yale University School of Medicine, New Haven, Conn. 06511.
Arch Gen Psychiatry. 1992 Nov;49(11):881-7. doi: 10.1001/archpsyc.1992.01820110045007.
Ninety-seven alcohol-dependent patients were treated for 12 weeks in a double-blind, placebo-controlled study evaluating naltrexone and two manual guided psychotherapies in the treatment of alcohol dependence. Patients were randomized to receive either naltrexone or placebo and either coping skills/relapse prevention therapy or a supportive therapy designed to support the patient's own efforts at abstinence without teaching specific coping skills. Naltrexone proved superior to placebo in measures of drinking and alcohol-related problems, including abstention rates, number of drinking days, relapse, and severity of alcohol-related problems. Medication interacted with the type of psychotherapy received. The cumulative rate of abstinence was highest for patients treated with naltrexone and supportive therapy. For those patients who initiated drinking, however, patients who received naltrexone and coping skills therapy were the least likely to relapse.
在一项双盲、安慰剂对照研究中,97名酒精依赖患者接受了为期12周的治疗,该研究评估了纳曲酮和两种手册指导心理疗法对酒精依赖的治疗效果。患者被随机分为接受纳曲酮或安慰剂,以及接受应对技能/预防复发疗法或旨在支持患者自行戒酒努力而不教授特定应对技能的支持性疗法。在饮酒和与酒精相关问题的测量方面,纳曲酮被证明优于安慰剂,包括戒酒率、饮酒天数、复发情况以及与酒精相关问题的严重程度。药物与所接受的心理治疗类型存在相互作用。接受纳曲酮和支持性疗法治疗的患者的累积戒酒率最高。然而,对于那些开始饮酒的患者,接受纳曲酮和应对技能疗法的患者复发可能性最小。